The Ophthalmologist
  • Explore

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Anterior Segment
    • Glaucoma
    • Retina

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Cataract
    • Cornea
    • Glaucoma
    • Neuro-ophthalmology
    • Oculoplastics
    • Optometry
    • Pediatric
    • Retina
  • Business

    Business & Profession

    • Professional Development
    • Business and Entrepreneurship
    • Practice Management
    • Health Economics & Policy
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Campaigns & Insights
Subscribe
Subscribe

False

Advertisement
The Ophthalmologist / Issues / 2026 / August / Standardizing SANS in Spaceflight
Health Economics and Policy Insights News

Standardizing SANS in Spaceflight

NASA experts set out new diagnostic and management guidance for spaceflight-associated neuro-ocular syndrome

8/27/2026 3 min read

Share

  • Full Article
  • Summary
  • Takeaways
  • Report
  • Scorecard
  • Quiz
  • Poll
  • Topic Commentary
5 Topic Commentaries

Standardizing SANS in Spaceflight

Standardizing SANS in Spaceflight

  • Mark J. Rosenberg
    Mark J. Rosenberg, MD

    Neurology (Aerospace Neurology)

    •

    Medical University of South Carolina

    There’s a necessity to make sure that we have appropriate standards now that we’re starting to have increased players in space flight, especially transport services with commercial entities starting to send people up. We need to make sure that there’s standardization so that we don’t have potential fatalities or complications that might affect human health. Ultimately, we need to make something that is inherently dangerous as safe as possible.

    Source
  • Michael A. Williams
    Michael A. Williams, MD

    Neurology

    •

    UW Medicine

    We want to be sure wherever we are, whatever planet we're on, we're using the same research standards for ethics. We want standards that are applicable to everybody who's participating in the research and that the research is going to benefit everybody, both in commercial spaceflight and national spaceflight. And by having larger numbers of research subjects, we have a better opportunity to get good results and to see something that may bring benefit to people on Earth.

    Source
  • Benjamin D. Levine
    Benjamin D. Levine, MD

    Cardiology; Environmental/Exercise Physiology

    •

    UT Southwestern Medical Center

    It would be a disaster if astronauts had such severe impairments that they couldn’t see what they’re doing and it compromised the mission.

    Source
  • Prem S. Subramanian
    Prem S. Subramanian, MD, PhD

    Neuro-ophthalmology

    •

    University of Colorado School of Medicine

    It’s a big issue because no one ever saw these SANS-type changes – the spaceflight associated neuro-ocular syndrome changes – until a person had been in space cumulatively for at least three months. The really concerning thing about it is that we’ve had people stay now six months, nine months, 12 months, and even a little bit longer, and there doesn’t seem to be a stopping point for when these changes plateau (in space). … And so, as a result, NASA has ranked SANS as the No. 2 human health hazard in spaceflight, with the only thing exceeding it being radiation exposure.

    Source
  • Nimesh Patel
    Nimesh Patel, OD, PhD, FAAO

    Vision Science; Optometry

    •

    University of Houston College of Optometry

    The results of these investigations suggest that, although there may be resolution of structural changes, there could be long-term ocular anatomical changes after extended-duration spaceflight.

    Source

This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.

Related Content

Newsletters

Receive the latest Ophthalmology news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

False

Advertisement

False

Advertisement

Explore More in Ophthalmology

Dive deeper into the world of Ophthalmology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement
The Ophthalmologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.

Affiliations:

Specialties:

Areas of Expertise:

Contributions:

Disclaimer

The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: